NCT02220608View on ClinicalTrials.gov

Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 20, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

Bortezomib

DRUG

G-CSF

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Washington University School of Medicine

OTHER